This case describes the Indonesian pharmaceutical market in 1997 and the impact on the market 75% devaluation of the Indonesian rupiah since July 1997. The main foreign and domestic players described. This raises the question of how the Indonesian pharmaceutical market may change as a result of the crisis and whether the balance of power between local and global players has changed. In the pharmaceutical industry, the Asian market - including South East Asia, Japan, China, Korea and India -. Accounted for one third of global income and experienced above average growth "Hide
by Carin-Isabel Knoop, Anthony St. George's 17 pages. Publication Date: April 15, 1998. Prod. #: 898220-PDF-ENG
Related Case Solutions & Analyses:
Airwide International-China (A) Key Account Selling
Revenue Recognition and Multiple Deliverables: Disentangling Revenue Streams at Fluidigm
Global Customer Management Programs: How To Make Them Really Work
The Gail Palmer Ashton Graduate School of Business: The Balanced Scorecard Initiative
The Politics and Economics of Accounting for Goodwill at Cisco Systems (B)
Another Kuwait Bank Ibrahim Dabdoub
A Glossary of Technical Terms Related to Bankruptcy in the U.S.
Banque Alpha (C)
Transforming Southcorp Ltd
“Buy”, “Sell”, or “Hold”: Analyzing the Analysts’ Recommendations
